BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28978161)

  • 1. Thymosin-β4 inhibits proliferation and induces apoptosis of hepatic stellate cells through PI3K/AKT pathway.
    Zhu L; Cheng M; Liu Y; Yao Y; Zhu Z; Zhang B; Mou Q; Cheng Y
    Oncotarget; 2017 Sep; 8(40):68847-68853. PubMed ID: 28978161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of thymosin β4 promotes the proliferation, migration, and activation of human hepatic stellate cells.
    Xiao Y; Qu C; Ge W; Wang B; Wu J; Xu L; Chen Y
    Cell Physiol Biochem; 2014; 34(2):356-67. PubMed ID: 25060912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic stellate cells express thymosin Beta 4 in chronically damaged liver.
    Kim J; Wang S; Hyun J; Choi SS; Cha H; Ock M; Jung Y
    PLoS One; 2015; 10(3):e0122758. PubMed ID: 25826335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential role of thymosin Beta 4 in liver fibrosis.
    Kim J; Jung Y
    Int J Mol Sci; 2015 May; 16(5):10624-35. PubMed ID: 26006229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymosin-β4 Mediates Hepatic Stellate Cell Activation by Interfering with CircRNA-0067835/miR-155/FoxO3 Signaling Pathway.
    Zhu L; Ren T; Zhu Z; Cheng M; Mou Q; Mu M; Liu Y; Yao Y; Cheng Y; Zhang B; Cheng Z
    Cell Physiol Biochem; 2018; 51(3):1389-1398. PubMed ID: 30481761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells.
    Kim J; Jung Y
    Vitam Horm; 2016; 102():121-49. PubMed ID: 27450733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tβ4 suppresses lincRNA-p21-mediated hepatic apoptosis and fibrosis by inhibiting PI3K-AKT-NF-κB pathway.
    Yang L; Fu WL; Zhu Y; Wang XG
    Gene; 2020 Oct; 758():144946. PubMed ID: 32649978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin β4 attenuates liver fibrosis via suppressing Notch signaling.
    Hong Y; Yao Q; Zheng L
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1396-1401. PubMed ID: 28965947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Deletion of Thymosin Beta 4 in Hepatic Stellate Cells Ameliorates Liver Fibrosis in a Transgenic Mouse Model.
    Kim J; Lee C; Han J; Jeong H; Wang S; Choi YH; Jung Y
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin β4 inhibits PDGF-BB induced activation, proliferation, and migration of human hepatic stellate cells via its actin-binding domain.
    Shah R; Reyes-Gordillo K; Rojkind M
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):177-184. PubMed ID: 30063851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF-κB pathway.
    Wang Z; Zhang Y; Wang Y; Mou Q; Ren T; Zhu L
    J Biochem Mol Toxicol; 2023 Jul; 37(7):e23338. PubMed ID: 37211724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 Exerts a Cytoprotective Function and Attenuates Liver Injury in Murine Hepatic Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
    Wang X; Zhou Y; Sun Q; Zhang Q; Zhou H; Zhang J; Du Y; Wang Y; Yuan K; Xu L; Zhang M; Yan D; Zeng L; Xu K; Sang W
    Transplant Cell Ther; 2023 Aug; 29(8):492.e1-492.e10. PubMed ID: 37192732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Slit2-Robo1 signaling promotes liver fibrosis.
    Chang J; Lan T; Li C; Ji X; Zheng L; Gou H; Ou Y; Wu T; Qi C; Zhang Q; Li J; Gu Q; Wen D; Cao L; Qiao L; Ding Y; Wang L
    J Hepatol; 2015 Dec; 63(6):1413-20. PubMed ID: 26264936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymosin β4 induces invasion and migration of human colorectal cancer cells through the ILK/AKT/β-catenin signaling pathway.
    Piao Z; Hong CS; Jung MR; Choi C; Park YK
    Biochem Biophys Res Commun; 2014 Sep; 452(3):858-64. PubMed ID: 25218472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetramethylpyrazine inhibits angiotensin II-induced activation of hepatic stellate cells associated with interference of platelet-derived growth factor β receptor pathways.
    Zhang X; Zhang F; Kong D; Wu X; Lian N; Chen L; Lu Y; Zheng S
    FEBS J; 2014 Jun; 281(12):2754-68. PubMed ID: 24725506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymosin β4 Suppresses LPS-Induced Murine Lung Fibrosis by Attenuating Oxidative Injury and Alleviating Inflammation.
    Tian Z; Yao N; Wang F; Ruan L
    Inflammation; 2022 Feb; 45(1):59-73. PubMed ID: 34414534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of miR-200b in biliary atresia patients accelerates proliferation and migration of hepatic stallate cells by activating PI3K/Akt signaling.
    Xiao Y; Wang J; Chen Y; Zhou K; Wen J; Wang Y; Zhou Y; Pan W; Cai W
    Cell Signal; 2014 May; 26(5):925-32. PubMed ID: 24412919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway.
    Trenkwalder T; Deindl E; Bongiovanni D; Lee S; Schunkert H; Kupatt C; Hinkel R
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S175-85. PubMed ID: 25652683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt signaling in liver fibrosis: progress, challenges and potential directions.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Biochimie; 2013 Dec; 95(12):2326-35. PubMed ID: 24036368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.